Filing Details
- Accession Number:
- 0000899243-16-026413
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-08-05 16:05:47
- Reporting Period:
- 2015-08-07
- Filing Date:
- 2016-08-05
- Accepted Time:
- 2016-08-05 16:05:47
- Original Submission Date:
- 2015-08-07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559053 | Prothena Corp Plc | PRTA | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242880 | S Christopher Henney | C/O Prothena Biosciences Inc 650 Gateway Boulevard South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value $0.01 Per Share | Acquisiton | 2015-08-07 | 10,000 | $6.65 | 10,000 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value $0.01 Per Share | Disposition | 2015-08-07 | 4,400 | $62.34 | 5,600 | No | 4 | S | Direct | |
| Ordinary Shares, Par Value $0.01 Per Share | Disposition | 2015-08-07 | 4,560 | $63.25 | 1,040 | No | 4 | S | Direct | |
| Ordinary Shares, Par Value $0.01 Per Share | Disposition | 2015-08-07 | 1,040 | $64.03 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2015-08-07 | 10,000 | $0.00 | 10,000 | $6.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,000 | 2023-03-18 | No | 4 | M | Direct |
Footnotes
- The transaction was executed in multiple trades in prices ranging from $61.785 to $62.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The transaction was executed in multiple trades in prices ranging from $62.80 to $63.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The transaction was executed in multiple trades in prices ranging from $63.84 to $64.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The shares subject to the option are fully vested and exercisable as of the date hereof.
- In the original Form 4 filed on August 7, 2015, due to an administrative error, the purchase price in column four of row one of Table I was incorrectly listed as $6.41, rather than the correct purchase price of $6.65. This amendment is filed to correct the Form 4 to report the acquisition price of $6.65 per share under the reported transaction.
Billionaire Hedge Funds
